Hypertension II: Pathophysiology
Hypertension and Regulation of Blood Pressure
Hypertension I: Introduction
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension V: Nursing Management
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Oct 13, 2025

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
Published on: May 26, 2022
Alexandra Bachinsky1, Erin Leah Jones, Tiffany Thompson
1At the time this article was written, Alexandra Bachinsky, Erin Leah Jones , and Tiffany Thompson were students in the PA program at the University of Lynchburg in Lynchburg, Va. Sondra DePalma practices at PinnacleHealth CardioVascular Institute in Harrisburg, Pa., is an adjunct assistant professor at A.T. Still University in Mesa, Ariz., and is director of regulatory and professional practice for the American Academy of PAs in Alexandria, Va. Joyce Nicholas is director of evaluation, assessment, and compliance and a professor in the PA program at the University of Lynchburg. Eric Schmidt is an assistant professor in the PA program at the University of Lynchburg. The authors have disclosed no potential conflicts of interest, financial or otherwise.
Resistant hypertension, affecting 17% of US adults, is hard to diagnose due to various factors. Early identification and management are crucial for better blood pressure control and reducing associated health risks.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: